top of page


Cell and Gene Therapy Updates
May 3rd Week, 2025 ⭐ Regulatory Update 🎯 The US FDA granted the RMAT designation to BrainChild Bio ’s BCB-276 (an autologous, B7-H3...
Oncofocus Team
6 days ago2 min read
2 views


CGT Watch Newsletter: May'25 Edition
Welcome to the May edition of our CGT Watch newsletter! CARsgen’s satri-cel priority review & Ph2 results; Autolus’ obe-cel positive...
Oncofocus Team
Jun 209 min read
1 view


Targeting the PD-1/PD-L1 immunosuppressive axis: CAR-T strategies under investigation
PD-(L)1 axis inhibits CAR-T cell activation, proliferation, survival, and functionality. Thus, CAR-T mediated direct targeting of the...
Oncofocus Team
Jan 11, 20241 min read
385 views
bottom of page